Transforming Clinical Development with AI

Update: 2025-02-13

Description

Bhaskar Sambasivan, CEO of Saama, sits down with Nagaraja Srivatsan to discuss the transformative role of AI in clinical development, why AI adoption will be a CEO mandate, and why the future of AI in drug development will be about autonomous decision-making.

Comments

In Channel

Redefining Biomarkers for Immune-Mediated Disease with AI

2025-11-1300:01

Driving Insights from Real World Oncology Data with AI

2025-10-2303:45

Improving Drug Development with Real-World Data

2025-10-0901:00:44

Navigating the AI Landscape in Clinical Development

2025-09-2547:36

Transforming Cancer Diagnostics and Care with AI

2025-09-1159:28

Moving Beyond the Hype of AI in Biopharma

2025-08-2843:30

Why AI’s Most Promising Near-Term Value Is in Clinical Operations

2025-08-1449:10

Teaching the Biopharma Workforce to Coexist with AI

2025-07-2447:03

Making Clinical Trials More Predictable with AI

2025-07-1441:31

Finding Healthcare Providers from Clinical Trials to War Zones

2025-06-2639:56

Driving Efficiency in Drug Development with AI

2025-06-1246:57

Improving Clinical Trial Designs with AI

2025-05-2957:39

Improving the Efficiency of the Pharma Workforce with AI

2025-05-1538:02

Navigating AI Implementation in Pharma

2025-04-2442:53

Transforming Cancer Care in India with AI

2025-04-1036:10

Navigating the Challenges of Integrating AI in Clinical Development

2025-03-2740:22

Leveraging AI in Clinical Development

2025-03-1337:30

Integrating AI into Precision Medicine

2025-02-2739:21

Transforming Clinical Development with AI

2025-02-1335:07

Generating Proteins Nature Never Imagined

2024-12-1201:05:44

00:00

1.0x

Transforming Clinical Development with AI

#box-pro-ellipsis-176349666204332{-webkit-line-clamp:2;}Transforming Clinical Development with AI

Transforming Clinical Development with AI

Levine Media Group

Transforming Clinical Development with AI